Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Surgery,
Ellis Fischel Cancer Center,
Molecular Microbiology and Immunology
Xiaoqiang Qi has not added Biography.
If you are Xiaoqiang Qi and would like to personalize this page please email our Author Liaison for assistance.
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
Journal of hepatology Jan, 2017 | Pubmed ID: 27520877
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Gastroenterology 03, 2018 | Pubmed ID: 29408569
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer.
Journal of immunology research and therapy , 2018 | Pubmed ID: 30123861
Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death.
Cancer letters Jul, 2019 | Pubmed ID: 31004701
University of Missouri-Columbia
Xiaoqiang Qi*,1,2,3,
Emily Schepers*,1,2,
Diego Avella1,2,
Eric T. Kimchi1,2,
Jussuf T. Kaifi1,2,
Kevin F. Staveley-O'Carroll1,2,
Guangfu Li1,2,3
1Department of Surgery, University of Missouri-Columbia,
2Ellis Fischel Cancer Center, University of Missouri-Columbia,
3Molecular Microbiology and Immunology, University of Missouri-Columbia
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved